Idiopathic Urticaria
📧 Sign up to get email alerts when something new happens for Idiopathic Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results comp…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria [Phase 3]
Phase 3 trial comparing TEV-45779 with Xolair (omalizumab) in adults with chronic idiopathic urticaria has completed and posted results on 2…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria [Phase 3]
Phase 3 study comparing ADL-018 with XOLAIR (Omalizumab) in adults with Chronic Idiopathic Urticaria has completed. The trial evaluated effi…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994) [Phase 3]
Phase 3 trial evaluating the safety of desloratadine in children with allergy sensitivity and chronic hives who are poor metabolizers of des…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) [Phase 4]
Phase 4 trial comparing continuous dosing of Aerius (cetirizine) to as-needed dosing in chronic idiopathic urticaria. The study has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) [Phase 4]
A Phase 4 double-dummy trial compared desloratadine 5 mg daily, cetirizine 10 mg daily, and placebo in adults with chronic idiopathic urtica…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Molecular Endotypes of Chronic Idiopathic Urticaria [Phase 4]
Phase 4 clinical trial update on molecular endotypes of chronic idiopathic urticaria; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) [Phase 4]
Phase 4 randomized, double-blind, double-dummy study comparing desloratadine 5 mg, cetirizine 10 mg, and placebo in chronic idiopathic urtic…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988) [Phase 3]
Phase 3 trial evaluating desloratadine (Clarinex, Aerius) and its impact on quality of life in chronic idiopathic urticaria patients with hi…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540) [Phase 4]
Phase 4 open-label study assessing desloratadine's effect on quality of life in chronic idiopathic urticaria patients; completed.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases [Phase 2]
Phase 2 trial evaluating KPL-716 for reducing pruritus in chronic pruritic diseases completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU) [Phase 4]
Phase 4 trial update evaluating IgE-bearing cells in chronic idiopathic urticaria has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Mast Cell Activation Test in Allergic Disease
Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody [Phase 4]
Phase 4 trial update evaluating an anti-IL5Ralpha monoclonal antibody for chronic idiopathic urticaria unresponsive to H1 antihistamines.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria [NA]
This completed single-center trial investigated biomarkers and response to omalizumab (Xolair) therapy in chronic idiopathic urticaria. The …
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AZD1981, a CRTh2 antagonist, in chronic idiopathic urticaria; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Efficacy Study of Canakinumab to Treat Urticaria [Phase 2]
Phase 2 clinical trial update evaluating canakinumab for chronic idiopathic urticaria; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria [Phase 2]
This clinical trial update reports on a Phase 2 study of methotrexate for chronic idiopathic urticaria, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment [Phase 2]
A Phase 2 study evaluating the mode of action of omalizumab in chronic idiopathic urticaria patients who do not respond to antihistamines; r…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria [Phase 3]
Phase 3 trial update discusses the efficacy and safety of omalizumab for chronic idiopathic urticaria.
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients [Phase 2, Phase 3]
Prospective double-blind, placebo-controlled trial of omalizumab (Xolair) in chronic urticaria, spanning Phase 2 and Phase 3 cohorts.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria [Phase 3]
A Phase 3 trial comparing the efficacy and safety of levocetirizine versus loratadine for chronic idiopathic urticaria has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists [Phase 3]
Phase 3 safety study of Xolair (omalizumab) in adults with chronic idiopathic urticaria who remain symptomatic despite H1 antihistamines, H2…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of omalizumab (Xolair) in chronic idiopathic urticaria and chronic spontaneous urticaria …
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) [Phase 3]
Phase 3 trial evaluating the efficacy, duration of response, and safety of Xolair (omalizumab) in patients with chronic idiopathic urticaria…